Gamma Tocopherol and Lovastatin Additively Induced Apoptosis in Human Colorectal Carcinoma Cell Line (HT29)
Leila Zeidooni1, Mohsen Rezaei1, Mahmood Hashemi Tabar2
1Department of Toxicology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran.
Background:
Programmed cell death (apoptosis) is a physiological process needed to remove unwanted or damaged cells. It has been hypothesized that any failure of programmed cell death leads to the development of neoplasm. Identifying new agents which induce apoptosis in tumor cells is of great significance in treatment of neoplasms. Numerous studies suggest that exposure of tumor cells to statins and gamma tocopherol can lead to cell death.
Objectives:
The aim of this study was to evaluate the cell death induced by gamma tocopherol and lovastatin in human colorectal carcinoma cell line (HT29) using flow cytometry.
Material And Methods:
HT29 cells were grown in DMEM medium, exposed to different concentrations of lovastatin (10,20,40,100μM ) and gamma tocopherol (25,50,100,200μM) for 48 and 72 hours, individually and in combination (100μM both, 48 h). Phenotype of apoptosis was determined by means of flow cytometry.
Results:
All Concentrations of lovastatin (10, 20, 40, 100 μM) and gamma tocopherol (25, 50, 100, 200 μM) induced an apoptotic response in HT29 cells. In combination, a significant increase in apoptosis phenotype was also demonstrated (P < 0.05).
Conclusions:
This study showed that lovastatin when combined with gamma tocopherol, could induce apoptosis in HT29 cells more potently than each agent alone, which uncovers the significance of targeting the proliferative signaling in different points of the pathway.
Insights
Lovastatin and gamma tocopherol induce apoptosis in colorectal cancer cells. Combining these agents significantly enhances the cell death, offering a potential new strategy for cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Programmed cell death (apoptosis) is crucial for eliminating damaged cells and preventing neoplasm development.
- Identifying novel apoptosis-inducing agents is vital for effective cancer treatment.
- Statins and gamma tocopherol show potential in inducing tumor cell death.
Purpose of the Study:
- To evaluate the apoptosis-inducing effects of gamma tocopherol and lovastatin on human colorectal carcinoma HT29 cells.
- To assess the combined efficacy of these agents in inducing cell death.
Main Methods:
- HT29 cells were treated with varying concentrations of lovastatin and gamma tocopherol for 48 and 72 hours.
- Apoptosis was quantified using flow cytometry.
- Cells were also treated with a combination of both agents.
Main Results:
- Both lovastatin and gamma tocopherol demonstrated dose-dependent induction of apoptosis in HT29 cells.
- The combination of lovastatin and gamma tocopherol resulted in a statistically significant increase in apoptosis.
- Flow cytometry confirmed the apoptotic phenotype.
Conclusions:
- Lovastatin and gamma tocopherol synergistically enhance apoptosis in colorectal carcinoma cells.
- Targeting proliferative signaling pathways with combined agents presents a promising therapeutic approach.
- This study highlights the potential of combined lovastatin and gamma tocopherol in cancer therapy.
Related Concept Videos
01:30Apoptosis
01:25Mutagenicity and Carcinogenicity
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
01:05Cancer-Critical Genes II: Tumor Suppressor Genes